Browse EX-10 agreements

[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and is treated by the Registrant as private or confidential.

CONFIDENTIAL

AMENDMENT NO.2 TO LICENSE AGREEMENT

THIS AMENDMENT NO.2 TO LICENSE AGREEMENT (this “Amendment No.2”),

effective as of June 15, 2023 (the “Amendment Date”), is made by and between:

Mitsubishi Tanabe Pharma Corporation, a company duly incorporated and existing under the laws of Japan with its principal office at 3-2-10, Dosho-machi, Chuo-ku, Osaka 541-8505, Japan (“MTPC”), on the one hand,

and

Mineralys Therapeutics, Inc., a corporation duly incorporated and existing under the laws of the state of Delaware having its principal place of business at 100 Pine Street, Suite 1250, San Francisco, CA 94111, U.S.A. (“MINERALYS”) on the other hand.

MTPC and MINERALYS may be referred to herein individually as a “Party” and collectively as the “Parties.”

RECITALS

WHEREAS, the Parties entered into LICENSE AGREEMENT dated July 9, 2020 relating to the license to develop and commercialize MT-4129 (as amended by AMENDMENT NO.1 TO LICENSE AGREEMENT dated November 24, 2020 by the Parties) (the “License Agreement”); and

WHEREAS, the Parties wish to revise, amend or supplement certain provisions of the License Agreement to provide certain data of MTPC Know-How to be incorporated into Exhibit C (MTPC Know-How as of the Effective Date) (as amended) as set forth herein and;

…

[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and is treated by the Registrant as private or confidential.

AMENDMENT NO. 1 TO LICENSE AGREEMENT

This AMENDMENT NO. 1 TO LICENSE AGREEMENT, dated as of November 24, 2020 (this “Amendment”), by and between Mitsubishi Tanabe Pharma Corporation, a corporation organized under the laws of Japan and having its principal place of business at 2-10 Dosho-machi, 3-chome, Chuo-ku, Osaka 541-8505, Japan (“MTPC”),and Mineralys Therapeutics, Inc., a corporation organized under the laws of the state of Delaware and having its principal of business at 100 Pine Street, Suite 1250, San Francisco, CA 94111, U.S.A. (“MINERALYS”).MTPC and MINERALYS are sometimes referred to individually as a “Party” and collectively “Parties”

WHEREAS, the Parties have entered into a License Agreement dated as of July 9, 2020 relating to the license to develop and commercialize MT-4129 (the “Agreement”); and

WHEREAS, the Parties desire to amend the Agreement as set forth below;

NOW, THEREFORE, in consideration of the foregoing, and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

1.Exhibit A “MTPC Patent Rights” of the Agreement shall be deleted and replaced with Exhibit A “MTPC Patent Rights” of this Amendment.

…

FIREFLY AEROSPACE INC.

OUTSIDE DIRECTOR COMPENSATION POLICY

POLICY STATEMENT

The purpose of this Outside Director Compensation Policy (the “Policy”) of Firefly Aerospace Inc., a Delaware corporation (the “Company”), is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors who are not employees or officers of the Company or its subsidiaries (“Outside Directors”). In furtherance of the purpose stated above, effective as of September 24, 2025 (as applicable, the “Effective Date”), all Outside Directors shall be paid compensation for services provided to the Company as set forth below:

Cash Retainers

•

Annual Retainer for Board Membership: $100,000 for general availability and participation in meetings and conference calls of our Board of Directors (the “Board”), to be paid in advance in four equal quarterly installments, to be paid promptly after the beginning of each calendar quarter. No additional compensation for attending individual Board meetings.

•

Additional Annual Retainers for Non-Executive Board Chair, Committee Chair, and Committee Membership: The additional retainers shall be paid in full and in advance following their respective appointments after each Annual Meeting of Stockholders (the “Annual Meeting”).

…

1 EXECUTION VERSION AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (this “Agreement”) by and between KLX Energy Services Holdings, Inc., a Delaware corporation (“Company”), and Christopher J. Baker (“Executive”) is entered into as of August 11, 2026 (the “Effective Date”). Executive and Company shall be referred to individually as a “Party” and collectively as the “Parties” within this Agreement. WHEREAS, effective as of July 28, 2020, Executive and Company entered into that certain Executive Employment Agreement (the “Original Employment Agreement”); WHEREAS, Company and Executive mutually desire to continue Executive’s employment with Company and to enter into this Agreement; and WHEREAS, this Agreement shall supersede and replace in its entirety the Original Employment Agreement, with the terms of Executive’s employment being set forth herein. NOW, THEREFORE, in consideration of the mutual promises, covenants, representations, obligations and agreements contained herein, and for other valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties agree as follows: 1. Term of Employment. The “Initial Term” of Executive’s employment hereunder shall commence on the Effective Date of this Agreement, and shall continue thereafter until the third (3rd) anniversary of the Effective Date, unless earlier terminated in accordance with the terms of this Agreement. After the expiration of the Initial Term, if not earlier terminated, this Agreement shall automatically renew on each anniversary of the

…

NOTICE OF RESTRICTED STOCK AWARD (EMPLOYEE)

[Date]

[Recipient Name & Address]

Dear ____________,

I am pleased to inform you that you have been granted a Restricted Stock Award of shares of Lee Enterprises, Incorporated Common Stock. You are receiving this award under the Company’s 2020 Long‑Term Incentive Plan (Effective February 19, 2020), as presently written or later amended (the “Plan”).

SUMMARY OF AWARD

Granted To: ______________________________

Grant Date: ______________________________

Fair Market Value per share of Common Stock: $         per share

Total Number of Shares of Restricted Stock: __________________

Total Number of Shares of Restricted

Stock Subject to the Restricted Period:

Vesting Schedule: Except as otherwise provided in this Notice or the attached Restricted Stock Award, you shall vest in the Restricted Stock in equal installments on each of the first (1st), second (2nd) and third (3rd) anniversaries of the Grant Date, subject to you providing continuous employment to the Company through such date .

LEE ENTERPRISES, INCORPORATED

By _________________________________

---

…

NOTICE OF PERFORMANCE STOCK UNIT AWARD (EMPLOYEE)

[Date]

[Recipient Name & Address]

Dear ____________,

I am pleased to inform you that you have been granted a Performance Stock Unit Award under the 2020 Long‑Term Incentive Plan of Lee Enterprises, Incorporated (Effective February 19, 2020), as presently written or later amended (the “Plan”).

SUMMARY OF AWARD

Granted To: ______________________________

Grant Date: ______________________________

Target Number of Performance Stock Units: __________________

Maximum Number of Performance Stock Units:

Performance Period:    [TBD]

Vesting Schedule: Except as provided in the Performance Stock Unit Award Agreement, the Performance Stock Units will vest and become nonforfeitable on the last day of the Performance Period, subject to the achievement of the minimum threshold Performance Goals for payout and the Grantee’s continuous employment through the last day of the Performance Period.

LEE ENTERPRISES, INCORPORATED

By _________________________________

---

…

AMENDMENT NO. 2 TO THE LETTER OF INTENT

This Amendment No. 2 to the Letter of Intent (this “Amendment No. 2”) is entered into as of August 6, 2026, by and between ONAR Holding Corporation, a Nevada corporation (“Purchaser”), and Advertise Purple, Inc.,** **a California corporation (the “Company”).

WHEREAS, Purchaser and the Company entered into that certain (i) non-binding letter of intent dated March 23, 2026 (the “LOI”), relating to the proposed acquisition of 100% of the equity interests of the Company by Purchaser or one of its subsidiaries (the “Transaction”), and (ii) Amendment No. 1 to the Letter of Intent dated July 27, 2026 (“Amendment No. 1”), amending the LOI as set forth therein;

WHEREAS, the parties desire to amend Amendment No. 1 as set forth herein; and

WHEREAS, Amendment No. 1 attached the Definitive Agreement as Exhibit B thereto and the parties desire to simultaneously amend the Definitive Agreement as set forth herein.

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

1. Defined Terms. Capitalized terms used but not defined in this Amendment No. 2 shall have the meanings ascribed to them in Amendment No. 1.

…

June 10, 2026

Manasi Jaiman, M.D., M.P.H.

Via email to […***…]

Re: Retention Bonus

Dear Manasi:

Aardvark Therapeutics, Inc. (the “Company”) is pleased to offer you the opportunity to receive a cash retention bonus in the aggregate amount of $357,000 (the “Retention Bonus”), on the following terms and conditions.

The Retention Bonus consists of two components: (i) the first component of the Retention Bonus ($204,000) is a guarantee of your 2026 annual bonus (the “Guaranteed Bonus Portion”), and (ii) the remaining component ($153,000) is intended solely as a retention bonus for your continued service through the Retention Date (as defined below). Your 2026 annual bonus, if any, based on the achievement of applicable goals, will be reduced (but not below zero) by the Guaranteed Bonus Portion.

The Company will pay you the Retention Bonus on January 1, 2027 (the “Retention Date”), subject to your continued employment with the Company through such date. However, if prior to the Retention Date, the Company terminates your employment without Cause (as defined in Exhibit A) or you resign for Good Reason (as defined in Exhibit A), subject to your execution and delivery to the Company of a full and complete release of any and all claims in a form prescribed by the Company that you execute and deliver to the Company (and that becomes effective and irrevocable within sixty (60) days after your termination of employment), the Company will pay you the Retention Bonus on the date occurring sixty (60) days following your termination of employment with the Company.

…